Owl Manor is a privately held medical device company dedicated to joint and soft tissue preservation of companion animals (equine and canine) through a portfolio of advanced joint lameness technologies. Spanning nearly 20 years of development, Owl Manor‘s portfolio includes Pro-Stride APS, Restigen PRP, and CenTrate BMA Concentrate, offering natural (from patient’s own blood), point-of-care convenience with clinically demonstrated effectiveness.